Osteonecrosis with renal damage in HIV patients undergoing HAART

Chitra, Pachiappan; Bakthavatsalam, Balakrishnan; Palvannan, Thayumanavan

doi:10.1016/j.biopha.2014.07.017

Cited by 2 publications

(1 citation statement)

References 39 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…У пациентов, страдающих псориазом, нередко происходит обострение заболевания на фоне ВИЧ-инфекции [8]. Развитие подагры также не является редкостью, поскольку не только длительно персистирующая ВИЧ-инфекция, но и развивающиеся при СПИД онкологические заболевания, а также проведе-ние АРВТ нередко способствуют значительному повышению уровня мочевой кислоты (МК) [9]. Напротив, применение ненуклеозидных ингибиторов обратной транскриптазы для лечения ВИЧ снижает риск гиперурикемии [10].…”

unclassified

Current issues in the management of patients with HIV infection and rheumatic diseases

Гриднева¹,

Белов²

2021

Sovremennaâ revmatologiâ

View full text Add to dashboard Cite

According to experts, the human immunodeficiency virus (HIV) epidemic has a steady downward trend, but the attention of the medical community to this problem is not waning. Before the introduction of highly active antiretroviral therapy, the prevalence of rheumatic manifestations in HIV-infected patients ranged from 3 to 71% and was associated with late stages of infection and severe immunosuppression. HIV-associated arthritis, reactive arthritis, psoriatic arthritis, arthralgias and diffuse infiltrative lymphocytosis syndrome are the most common rheumatic pathologies in HIV. Most people with HIV and musculoskeletal inflammatory disease respond well to NSAIDs, opioids, and basic anti-inflammatory drugs. In cases that are torpid to the abovementioned treatment, the use of biologic disease-modifying antirheumatic drugs may be required.The lecture summarizes modern data on the features of the course and treatment of immunoinflammatory rheumatic diseases in HIV infection.

show abstract

unclassified